Detrimental effects of energy drink consumption on platelet and endothelial function

Matthew I Worthley1, Anisha Prabhu, Paolo De Sciscio

  • 1Department of Cardiology, Cardiovascular Research Centre, Royal Adelaide Hospital, and Disciplines of Physiology and Medicine, University of Adelaide, Adelaide, Australia.

Insights

Energy drinks acutely impair blood vessel function and increase blood clot risk in healthy young adults. This study shows energy drink consumption negatively affects platelet aggregation and endothelial function.

Area of Science:

  • Cardiovascular Research
  • Human Physiology
  • Nutritional Science

Background:

  • Energy drink consumption is anecdotally linked to cardiac events like sudden cardiac death and myocardial infarction.
  • Myocardial infarction is strongly associated with platelet and endothelial dysfunction, prompting this investigation.

Purpose of the Study:

  • To test the hypothesis that energy drink consumption alters platelet and endothelial function.
  • To investigate the acute effects of energy drinks on cardiovascular markers in healthy adults.

Main Methods:

  • Fifty healthy volunteers consumed 250 mL of a sugar-free energy drink.
  • Platelet aggregation was measured using adenosine diphosphate-induced optical aggregometry.
  • Endothelial function was assessed via peripheral arterial tonometry, measuring the reactive hyperemia index (RHI).

Main Results:

  • Energy drink consumption significantly increased platelet aggregation compared to a control.
  • A significant decrease in the reactive hyperemia index (RHI) was observed post-consumption, indicating impaired endothelial function.
  • Mean arterial pressure increased, while heart rate remained unaffected.

Conclusions:

  • Energy drink consumption acutely increases platelet aggregation in healthy young adults.
  • Energy drink consumption acutely decreases endothelial function in healthy young adults.
  • These findings suggest a potential mechanism linking energy drink intake to adverse cardiovascular events.
Abstract

Related Concept Videos

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...